 Home > Active Ingredient News > Immunology News > Remsima, an anti-TNF-alpha monosomal subcutaneous formulation, was approved and the treatment time was reduced to 25 minutes.

Remsima, an anti-TNF-alpha monosomal subcutaneous formulation, was approved and the treatment time was reduced to 25 minutes.

 Last Update: 2020-08-06
 Source: Internet
 Author: User

Tags

atorvastatin drug

fluoxetine drug

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The European Commission approved Remsima, the world's first subcutaneous formulation of infliximab, for five other indications, including aggressive spina bifida (AS), Crohn's disease (CD), ulcerative colitis (UC), psoriasis arthritis (PsA) and psoriasis (PsopsyPstoclias).
photo source: Inphyseiamisis is a human rat chimeric monotortagain against the tumor necrosis factor (TNF-alpha), a subcutaneous preparation that can be administered by the patient himself, reducing the treatment time to about twenty-five minutes, and the efficacy and safety of the drug's intravenous formulation.
approval was made in June after receiving confirmation from the European Medicines Agency's Human Drug Commission, based on data from a key study that compared the pharmacodynamics, efficacy and safety parameters of Remsima's subcutaneous and intravenous preparations for one year in patients with active Crohn's disease and ulcerative colitis.
picture source: Abstracts of the 15th Of ECCO - European Crohn's and Colitis German Professor Stefan Schreiber said: "Remsima's approval marks an important development in the field of gastroenterology, which means that patients can be treated in less time, providing greater flexibility and changing the way treatment is treated.
"

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.